Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress CLBT Q1 2026 Earnings EPS Surpasses Estimates by Nearly 19 Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus EPAM Q1 2026 Earnings EPS Beats Estimates by 183 Amid Uncertain Revenue Trends Autoliv Inc ALV Q1 2026 Earnings EPS Beat Drives Modest Stock Gain PAM Q1 2026 Earnings EPS Surges to 21571 Smashing Estimates by Over 10980